FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution

DENVER, April 26, 2017 -- (Healthcare Sales & Marketing Network) -- Silvergate Pharmaceuticals, Inc. (www.silvergatepharma.com), leaders in the development and commercialization of innovative and safe medicines for children, today announced that the Unite... Biopharmaceuticals, FDA Silvergate Pharmaceuticals, XATMEP, methotrexate, arthritis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news